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Tyrosine phosphorylation events are key components of several cellular signal transduction pathways. This study 
describes a novel method for identification of substrates for tyrosine kinases. Co-expression of the tyrosine kinase 
EphB1 with the intracellular domain of guanylyl cyclase C (GCC) in Escherichia coli cells resulted in tyrosine 
phosphorylation of GCC, indicating that GCC is a potential substrate for tyrosine kinases. Indeed, GCC  
expressed in mammalian cells is tyrosine phosphorylated, suggesting that tyrosine phosphorylation may play a 
role in regulation of GCC signalling. This is the first demonstration of tyrosine phosphorylation of any member of 
the family of membrane-associated guanylyl cyclases. 
1. Introduction 
A change in tyrosine phosphorylation of proteins is an 
important mechanism of cellular signal transduction, and 
can regulate both protein function, as well as interaction 
with other proteins (Fantl et al 1993). Consequently, 
novel pathways in signalling cascades can be suggested by 
the identification and characterization of tyrosine phos-
phorylation sites in proteins. Classically, tyrosine phos-
phorylation sites have been identified by peptide mapping 
of phosphoproteins usually radiolabelled in vivo. Screen-
ing of peptide libraries has led to the identification of con-
sensus substrate sequences for specific protein kinases, 
making it possible to predict phosphorylation sites based 
on sequence analysis (Songyang et al 1995). In this study 
we describe another approach for the identification of 
novel tyrosine phosphorylation sites in a protein. This 
involves co-expression in Escherichia coli of a tyrosine 
kinase along with domains of a receptor guanylyl cyclase, 
earlier not known to undergo tyrosine phosphorylation. 
 Guanylyl cyclase C (GCC), the receptor for the family 
of heat-stable enterotoxin peptides and the guanylin fam-
ily of endogenous peptides, is known to play a role in the 
regulation of fluid and ion balance in the intestinal epithe-
lium (Drewett and Garbers 1994). Ligand mediated acti-
vation of GCC leads to an increase in intracellular cGMP 
l vels, which in turn leads to the activation of cyclic  
nucle tide-dependent protein kinases (Chao et al 1994; 
Vaandrager t al 1997). The activated kinases phosphory-
late and activate the cystic fibrosis transmembrane con-
ductance regulator (CFTR), thereby leading to an efflux 
of Cl– ions and fluid from the cells (Chao et l 1994). 
Analysis of GCC expression in the rat and opossum intes-
tine, by in situ hybridization (Li and Goy 1993; Krause  
et al 1994), and immunohistochemical studies (Nandi  
et al 1997), has shown that GCC is expressed in certain 
cell types in the intestine that do not express CFTR 
(Trezise and Buchwald 1991). This suggests that GCC 
may have other functions in the cell besides regulation of 
chloride secretion via the CFTR. One such possibility is 
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that GCC may undergo changes in phosphorylation, and 
this in turn mediates novel functions of GCC. 
 The regulation of GCC activity by protein kinase C 
mediated phosphorylation of a specific serine residue has 
been described earlier (Roy and Visweswariah 1998). In 
order to examine whether GCC is a substrate for tyrosine 
phosphorylation, we have utilized a novel method to exa-
mine whether the intracellular domain of GCC is tyrosine 
phosphorylated, by co-expression of various domains of 
GCC with the tyrosine kinase, EphB1/Elk (Lhotak et al 
1991; Eph Nomenclature Committee 1997). GCC was 
found to be tyrosine phosphorylated under these condi-
tions, indicating that it is a potential substrate for tyrosine 
kinases. We also demonstrate that GCC expressed in 
mammalian cells is indeed tyrosine phosphorylated, sug-
gesting that tyrosine phosphorylation of GCC may play a 
role in GCC mediated cellular signalling. 
 
2. Materials and methods 
2.1 Generation of anti-phosphotyrosine antibodies 
A polyclonal antiserum to phosphotyrosine was generated 
as described earlier (Kamps 1991b) and phosphotyrosine 
specific antibodies purified from the IgG fraction of the 
antiserum by affinity chromatography using phosphotyro-
sine linked to Affi-Gel 15 (Bio-Rad). This antibody was 
extensively characterized to show its specificity for phos-
photyrosine (data not shown). 
2.2 Construction of plasmids expressing various regions 
of the intracellular domain of GCC 
Subclones of the intracellular domain of GCC, repre-
sented diagrammatically in figure 3a, were constructed 
from pBSK-GCC (Singh et al 1991) as follows: 
 
(i) GCC-ID1: The 1626 bp fragment releas d on diges-
tion of pBSK-GCC by BamHI and SmaI was cloned into 
pGEX2T (Amersham Pharmacia Biotech, UK) to generate 
a plasmid expressing the recombinant protein designated 
GCC-ID1. This protein includes the C-terminal 507 amino 
acids of GCC as a fusion with glutathione S transferase 
(GST). 
(ii) GCC-protein kinase-like domain: A DNA fragment 
generated by digestion of pRSET-ID6 (Nandi et al 1997) 
with PvuII was cloned into the SmaI site of pGEX-5X2. 
This construct expresses the N- erminal 330 amino acids 
of the intracellular domain of GCC, encompassing the 
protein kinase-like domain (PKLD) of GCC, as a GST 
fusion. 
(iii) GCC-C-terminal domain: A 429 bp EcoRI frag-
ment from pBSK-GCC, was ligated into the EcoRI site of 
pGEX-5X2 to generate pGEX-CTD, which expresses the 
C-terminal 112 amino acids of GCC as fusion with GST. 
(iv) GCC-guanylyl cyclase domain: The cDNA coding 
for t e guanylyl cclase domain (GCD) of GCC (from Pro 
732 to the C-terminus) was obtained by PCR amplifica-
tion from pBSK-GCC, and cloned into pTrc99A at KpnI–
PstI sites. The primers used for amplification were (1) 
sen e strand: 5¢ CCA GAA AAG GTA CCA GAT TTC 
AAA 3¢, and (2) antisense strand: 5¢ CAT CTG CAG 
TTA AAA ATA GGT GCT 3¢. A KpnI–HindIII fragment 
from this clone was ligated into pRSET C (Invitrogen, 
USA). The resulting plasmid was digested with BamHI 
and HindIII, and ligated into BamHI-HindIII digested 
pGEX-CTD to generate a plasmid expressing the catalytic 
domain (342 amino acids) of GCC as a fusion with GST. 
2.3 Expression of fusion proteins in TKB1 
The BL21(DE3) pTK strain of E. coli (abbreviated TKB1), 
that harbours a plasmid encoding the tyrosin  kinase Elk 
(EphB1), was obtained from Stratagene (USA). Trans-
formation and induction of TKB1 cells was carried out as 
per the manufacturers’ protocol, with slight modifications. 
TKB1 cells transformed with the plasmid of interest were 
grown to an A600 of 0×5, in Luria Bertani broth containing 
antibiotics at 37°C. Cells were collected by centrifugation 
and resuspended in induction medium, containing 1 mM 
IPTG, to induce the gene of interest, and 10mg/ml b  
Indole acrylic acid, to induce expression of the ephB1 
gene. Cells were grown for an additional 3 h at 37°C, col-
lected by centrifugation and sonicated (Virtis 475 sonica-
tor) in 50 mM Tris-Cl pH 8×0, 5 mM 2-mercaptoethanol, 
0×1 M NaCl, 2 mM benzamidine, 5mM EDTA, 100 mM 
sodium orthovanadate, 50 mM sodium fluoride and 1% 
Triton X-100. Fractionation of the cell lysates by cen-
trif ga ion at 10,000 g for 20 min, and analysis by SDS-
PAGE revealed that the proteins were predominantly  
localized to the inclusion body fraction. 
2.4 [32P]-labelling of TKB1 cells 
TKB1 cells expressing GCC-ID1 were grown in Luria 
B rtani broth to an A600of 0×5, collected by centrifugation 
and resuspended in 50 mM HEPES, pH 7×5, 19 mM 
NH4Cl, 8 mM NaCl, 20 mM CaCl2, 1 mM MgSO4, 0×2% 
glucose, 0×1% casamino acids, 0×00005% thiamine, 
100 mg/ml of ampicillin, and 12×5 mg/ml tetracycline. 
[32P]-orthophosphate (500 mCi per 10 ml culture, specific 
activity 8500 Ci/mmol, NEN Life Science Products) was 
added to the medium, cells grown at 37°C for 1 h and 
induced for an additional 3 h by the addition of IPTG and 
b Indole-acrylic acid. Cells were harvested and lysed as 
described above, and [32P]-labelled protein purified from 
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the inclusion body fraction by electroelution from poly-
acrylamide gels (Nandi et al 1997). 
2.5 Immunoprecipitation, phosphoamino acid analysis and 
phosphopeptide mapping of radilabelled GCC-ID1 
Approximately 20mg of [32P]-labelled purified GCC-ID1, 
was diluted in RIPA buffer (50 mM Tris-Cl, pH 8×0, 1% 
NP40, 0×5% sodium deoxycholate, 0×1% SDS and 
150 mM NaCl), containing 1 mg/ml BSA, 5 mM EDTA, 
50 mM sodium fluoride, 1 mM benzamidine, 100 mM 
sodium orthovanadate and 1 mg/ml leupeptin. The protein 
was incubated with normal mouse IgG (7 mg, Sigma), or 
GCC monoclonal antibody, GCC:C8 (7 mg; Bakre et al 
2000), normal rabbit IgG (12 mg) or affinity purified anti-
phosphotyrosine polyclonal IgG (12 mg) at 4°C for 12 h, 
and the immune complexes precipitated with Protein A 
Sepharose beads (Life Technologies, USA). The Protein 
A beads were washed sequentially with RIPA buffer and 
phosphate buffered saline, boiled in SDS sample buffer, 
and subjected to SDS-PAGE in a 10% polyacrylamide 
gel. The gel was fixed and stained prior to exposing to 
Kodak XK-5 film at – 70°C. 
 For phosphoaminoacid analysis, GCC-ID1 inclusion 
body fraction containing the radiolabelled protein, was 
resolved by SDS-PAGE and electroblotted onto a poly-
vinylidene difluoride (PVDF) membrane (Immobilon-P, 
Millipore). The radiolabelled protein on the membrane 
was hydrolysed (Kamps 1991b), the resulting phospho-
amino acids separated by one-dimensional thin-layer elec-
trophoresis at pH 3×5 (Boyle et al 1991) and visualized by 
autoradiography. 
 The inclusion body fraction containing radiolabelled 
GCC-ID1 was subjected to reduction and carboxyamida-
tion in the presence of 1% SDS, 5 mM DTT and 25 mM 
iodoacetamide, according to standard procedures (Carne 
1994). The reduced and carboxyamidated proteins were 
resolved by SDS-PAGE and transferred onto a nitrocellu-
lose membrane. The band of interest was subjected to 
tryptic digestion and phosphopeptide mapping (Boyle  
et al 1991). 
2.6 Detection of tyrosine phosphorylation of GCC in 
HEK293-GCC cells 
We have earlier reported the generation of the cell line 
HEK293-GCC that expresses high levels of human GCC 
(Bakre et al 2000). HEK293-GCC cells were lysed by 
sonication in 50 mM HEPES, pH 7×4, 100 mM NaCl, 
10% glycerol, 1 mM DDT, 5 mM EDTA, 1 mM sodium 
orthovanadate, 50 nM okadaic acid, 100 mM sodium fluo-
ride, 10 mM sodium pyrophosphate, 80 µM b-glycerol 
phosphate, 5 µg/ml soyabean trypsin inhibitor, 5 µg/ml 
aprotinin and 5 µg/ml leupeptin. The membrane fraction 
was obtained from the cell lysate by centrifugation at 
10,000 g for 1 h, and solubilized in immunoprecipitation 
buffer (20 mM Tris-HCl, pH 7×5, 1% Triton-X100, 0×5% 
Nonidet P 40, 150 mM sodium chloride, 1 mM EDTA, 
200 µM sodium orthovanadate, 50 nM okadaic acid, 
100 mM sodium fluoride, 10 mM sodium pyrophosphate, 
80 µM b-glycerol phosphate, 5 µg/ml soyabean trypsin 
inhibitor, 5 µg/ml aprotinin and 5 µg/ml leupeptin). The 
solubilized sample was pre-cleared by incubation with 
5 µg/ml normal mouse IgG for 10 h at 4°C followed by 
10 µl Protein A Sepharose beads for 2 h at 4°C. Immuno-
precipitation was carried out by incubation with 5 µg/ml 
GCC:4D7 monoclonal antibody raised to the PKLD of 
GCC (unpublished results), for 10 h at 4°C, followed by 
Protein A Sepharose beads for 2 h at 4°C. The beads were 
washed extensively with immunoprecipitation buffer and 
boiled in SDS sample buffer. The immunoprecipitated 
proteins were resolved by SDS-PAGE in a 7×5% poly-
acrylamide gel and transferred to a PVDF membrane. 
West n blot analysis was carried out as described earlier 
(Bakre et al 2000) using the pY20 monocl al antibody 
(Transduction Labs, USA), followed by detection using 
ECL Plus reagent (Amersham Pharmacia Biotech, UK). 
Blots were subsequently stripped and re-probed with the 
GCC:C8 monoclonal antibody. 
3. Results 
3.1 Demonstration of tyrosine phosphorylation on GCC 
To examine whether GCC is a potential substrate for tyro-
sine kinases, we over-expressed the intracellular domain 
of GCC in TKB1. We were unable to obtain transformants 
of the plasmid expressing the entire intrac llular domain 
of GCC in TKB1 cells, and therefore expressed GCC-
ID1, a GST fusion of a part of the intracellular domain of 
GCC (aa 567-1073), in TKB1 cells. Expression of GCC-
ID1 in TKB1 cells in the presence of [32Pi] yielded [
32P]-
lab lled GCC-ID1, which was purified from the inclusion 
bod  fraction (figure 1a, lane 1). The identity of the  
labelled protein was confirmed by immunoprecipitation 
with a monoclonal antibody specific to the PKLD of GCC 
(figure 1a, lane 3). Moreover, immunoprecipitation of the 
radiolabelled protein was observed with phosphotyrosine 
antibodies (figure 1a, lane 5). Phosphoaminoacid analysis 
of [32P]-labelled GCC-ID1 revealed the presence of only 
radiolabelled phosphotyrosine, with no detectable amounts 
of phosphoserine and phosphothreonine (figure 1b). 
3.2 Analysis of tyrosine phosphorylation sites 
 in GCC-ID1 
Tryptic digestion and two-dimensional phosphopeptide 
mapping of [32P]-labelled GCC-ID1 indicated at least 12 
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major spots (figure 2). This could correspond to partially 
digested phosphopeptides, but could also indicate the 
presence of multiple sites of tyrosine phosphorylation in 
the intracellular domain of GCC. To investigate this pos-
sibility, we constructed various sub-clones of the intra-
cellular domain, (figure 3a), expressed these proteins in 
TKB1 and monitored tyrosine phosphorylation by West-
ern blotting with anti-phosphotyrosine antibodies (figure 
3b). As demonstrated earlier by phosphoaminoacid ana-
lysis, GCC-ID1 was tyrosine phosphorylated when  
expressed in TKB1 cells, but not when expressed in the 
BL21(DE3) strain. GST alone, expressed in TKB1 cells 
was not tyrosine phosphorylated, indicating that the phos-
phorylation detected in GCC-ID1 was present only in the 
GCC fragment of the protein. The lack of phosphorylation 
of GST by EphB1 has also been reported earlier by  
the use of a similar expression system (Larose et al  
1993). 
 The PKLD of GCC, (GCC-PKLD), expressed in TKB1, 
was phosphorylated on tyrosine (figure 3b), as was the 
sub-clone GCC-GCD, which spans the guanylyl cyclase 
domain. Since there are only two tyrosine residues in the 
53 amino acid overlap between GCC-PKLD and GCC-
GCD (Pro732 to Gln 784), it is possible that sites phos-
phorylated in PKLD and GCD may be distinct. The GCC 
sub-clone spanning the C-terminal domain, GCC- TD, 
was also phosphorylated in TKB1. It can be concluded, 
therefore, that at least two sites for tyrosine phosphoryla-
tion could be present in the intracellular domain of GCC. 
As can be seen, utilization of the TKB1 strain allowed  
us to suggest that a protein not hither to known to be  
Figure  2. Phosphopeptide map analysis of GCC-ID1 ex-
pressed in TKB1. [32P]-labelled GCC-ID1 was digested with 
trypsin as detailed in the text and the resulting phosphopeptides 
spotted onto cellulose TLC plates and separated in two dimen-
sions. Spots were visualized following autoradiography. 
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Figure  1. Immunoprecipitation of [32P]-labelled GCC-ID1 and phosphoaminoacid analysis. (A) [32P]-labelled GCC-ID1 expressed 
in TKB1 cells was purified from the inclusion body fraction by electroelution (lane 1). This purified protein was incubated with 
either normal mouse IgG (lane 2), GCC:C8 monoclonal antibody (lane 3), normal rabbit IgG (lane 4) or polyclonal anti-
phosphotyrosine antibody (lane 5) and the immunoprecipitates analysed by SDS-PAGE followed by autoradiography. (B) [32P]-
labelled GCC-ID1 was subjected to hydrolysis as detailed in the text and products separated by electrophoresis on cellulose TLC 
plates, followed by autoradiogrphy. Migration of phosphoserine (pS), phosphothreonine (pT) and phosphotyrosine (pY) standards 
are indicated by dotted circles. 
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Figure  3. (A) Schematic representation of various subclones of the intracellular domain of GCC. GCC: guanylyl cyclase C; ED: 
extracellular domain; TM: transmembrane domain; ID: intracellular domain; N: N-terminus C C-terminus; PKLD: protein kinase-
like domain; GCD: guanylyl cyclase domain; CTD: C-terminal domain; GST: glutathione S-transferase. Open boxes in the intracel-
lular domain represent possible linker regions between the defined domains. (B) Expression of different regions of the intracellular 
domain of GCC in TKB1. Top panel: Coomassie Blue stained gel picture of inclusion body fractions (10 mg each) of GCC-ID1 
expressed in TKB1 (lane 1), GCC-ID1 expressed in BL21(DE3) (lane 2), GST expressed from th  pGEX-5X plasmid in TKB1 (lane 
3), GCC-PKLD in TKB1 (lane 4), GCC-GCD in TKB1 (lane 5) and GCC-CTD in TKB1 (lane 6), subjected to SDS-PAGE. Molecu-
lar weight standards are indicated on the left. Lower panel: The inclusion body fractions (0×5 mg each) as in the top panel were blot-
ted onto nitrocellulose membranes and probed with anti-phosphotyrosine antibody (0×6 mg/ml). Molecular weights of the expr ssed 
proteins are indicated by arrows. 
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phosphorylated on tyrosine may undergo tyrosine phos-
phorylation in mammalian cells. 
3.3 GCC expressed in HEK-293 cells is tyrosine  
phosphorylated 
The results presented so far suggest that GCC is a sub-
strate for phosphorylation by the EphB1 tyrosine kinase, 
and may perhaps be a substrate for other tyrosine kinases 
when expressed in mammalian cells. We immunoprecipi-
tated GCC from membranes prepared from HEK293-GCC 
cells, using a monoclonal antibody to GCC (GCC:4D7). 
Western blot analysis using an anti-phosphotyrosine anti-
body, confirmed that GCC was indeed tyrosine phos-
phorylated in mammalian cells (figure 4). Bands reacting 
with phosphotyrosine antibody co-migrated with the  
doublet of immunoreactive proteins (130 kDa and 145 kDa) 
detected by a GCC monoclonal antibody. The monoclo- 
nal antibody GCC:4D7 did not immunoprecipitate any 
proteins from COS7 cells (known not to express GCC) 
indicating that the bands detected with the phosphotyro-
sine antibody were specific to GCC, and not to any  
non-specific co-immunoprecipitating protein (data not  
shown). 
4. Discussion 
To our knowledge, the present study is the first report of 
the use of the TKB1 E. coli strain to demonstrate tyrosine 
phosphorylation of a mammalian protein that was to date 
not known to be phosphorylated on tyrosine residues, and 
suggests the utility of the TKB1 system to identify novel 
substrates for tyrosine kinases. In principle, expression of 
a protein of interest along with any tyrosine kinase in  
E. coli cells could be employed to identify substrates for 
other tyrosine kinases. Such an expression system allows 
the generation of large amounts of tyrosine phosphory-
lated protein, which can in turn be used to identify inter-
acting proteins, perhaps containing SH2 domains. A 
similar expression strategy using EphB1 expression in 
bacteria has been used by Larose et al (1993) to identify 
residues in the platelet derived growth factor receptor that 
bind to the SH2 domain of phospholipase C-g1. 
 Our study is the first to demonstrate tyrosine phos-
phorylation of a member of the family of receptor 
guanylyl cy lases. Earlier studies on the ANF receptor 
(guanylyl cyclase A, GCA), another member of this 
family of receptors, have demonstrated that GCA exp-
ressed in mammalian cells is phosphorylated on serine 
and threonine residues but not on tyrosine (Koller t al 
1993; Potter and Garbers 1992, 1994). Although there is 
significant sequence similarity between the intracellular 
domains of the natriuretic peptide receptors and GCC 
(deSauvage et al 1991; Singh et al 1991), this difference 
in tyrosine phosphorylation could indicate that tyrosine 
phosphorylation is a unique feature of GCC and does not 
occur in other members of this family.
 Tyrosine phosphorylation of the intracellular domain of 
GCC by EphB1 within bacterial cells suggests that GCC 
may be a substrate for the Eph family of tyrosine kinases 
in mammalian cells as well. Although EphB1 is not  
expressed in the intestine (Tang et l 1995), which is the 
major site of GCC expression, other members of this  
family, including EphA2 (Eck; Lindberg and Hunter 
1990), and the mouse homologues EphB4 (MDK2) and 
EphB3 (MDK5; Ciossek et al 1995), are present in the 
intestine. Also, EphB1 is detect d in the testis and kidney 
(Tang et al 1995), where the expression of GCC has been 
demonstrated (Forte et al 1989; Laney et al 1992), and 
perhaps also in HEK293 cells, where we have demonstra-
ted GCC tyrosine phosphorylation. A family of gut-
associated tyrosine kinases (Sunitha and Avigan 1996) 
are highly expressed in cell types in the intestine, which 
also express GCC (Nandi et al 1997). Furthermore, high 
levels of pp60c-src have been reported in colonic carci-
noma cells, including T84 cells that express GCC (Cart-
wright et al 1989). It would be interesting to explore the 
possibility that GCC may be a substrate for these tyrosine 
kinases in the intestine and perhaps in other tissues. 
 We have been able to demonstrate that GCC is tyrosine 
phosphorylated in mammalian cells. The role of tyrosine 
ph sphorylation in GCC function now remains to be exa-
mined. It is possible that changes in tyrosine phosphoryla-
tion may modulate GCC activity. Tyrosine phosphorylation 
Figure  4. Tyrosine phosphorylation of GCC in HEK293-
GCC cells. The solubilized membrane fraction from HEK293-
GCC cells was incubated with normal mouse IgG (lane 1) or 
GCC:4D7 monoclonal antibody (lane 2) and immune complexes 
collected on protein A beads. Immunopreci itated proteins were 
subjected to Western blot analysis with phosphotyrosine anti-
bodies (left panel; pY20), followed by reprobing of the blot 
with a GCC-specific monoclonal antibody (right panel; 
GCC:C8). Molecular weights represent the sizes of the two 
differentially glycosylated forms of GCC in HEK293-GCC 
cells. 
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of GCC may also mediate interaction of GCC with other 
pathways in the cell. On phosphorylation, certain tyrosine 
residues may serve as sites for interaction of GCC with 
other intracellular proteins containing SH2 or PTB domains 
(Shoelson 1997), thereby leading to additional signal 
transduction events involving GCC. Answers to these 
questions will be available only when individual sites for 
tyrosine phosphorylation in GCC are characterized, and 
mutagenesis studies carried out to understand the role of 
GCC phosphorylation at such sites. 
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